READ THE LATEST NEWS FROM OUR LAW FIRM, LEGISLATION AND CROATIA.
The completion of the sale of Cardinal Health’s Cordis business to Hellman & Friedman has been publicly announced. The sale price is approximately $1 billion and includes the buyer’s assumption of certain liabilities and the seller’s retention of certain working capital accounts. Cardinal Health plans to release its fourth-quarter and year-end financial results for its fiscal year 2021 on August 5 prior to the opening of trading on the New York Stock Exchange.
Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for health care facilities. Cardinal Health is 50 years in business, operates in more than 40 countries and has approximately 48,000 employees globally.
Hellman & Friedman is a global private equity firm with a distinctive investment approach focused on large-scale equity investments in high quality growth businesses. The firm is currently investing its tenth fund, with over $24 billion of committed capital, and has over $80 billion in assets under management and committed capital.
This site uses basic cookies that allow you to improve its features and content and analyze its usage. By clicking on accept you agree to the above.